Formosa Pharmaceuticals, Inc. (TPE:6838)

Formosa Pharmaceuticals Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	52.59	9.5	143.36	31.17	1.32	28.53
Revenue Growth	237.39%	-93.38%	359.89%	2270.49%	-95.39%	-
Gross Profit Gross Profit Growth	30.16	-1.6	118.99	27.35	0.33	28.26
Operating Income Operating Income Growth	-170.33	-170.61	-175.63	-283.04	-381.67	-380.01
Net Income Net Income Growth	-190.05	-83.57	-201.01	-321.96	-406.27	-400.88
Earnings Per Share EPS Growth	-1.25	-0.55	-1.43	-2.59	-3.86	-4.33
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Taiwan Taiwan Growth	-	0.37	-	1.32	28.53
Asia Asia Growth	4.73	7.16	31.17	-	-
America America Growth	4.76	135.82	-	-	-
Total Total Growth	9.5	143.36	31.17	1.32	28.53

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	1,217	1,442	1,646	1,216	420.89	208.92
Total Debt Total Debt Growth	24.71	26.99	25.8	29.79	6.9	3.18
Net Cash (Debt) Net Cash Growth	1,192	1,415	1,620	1,186	413.99	205.74
Net Cash Growth	-22.48%	-12.67%	36.55%	186.56%	101.22%	476.99%
Net Cash Per Share Net Cash Per Share Growth	7.81	9.37	11.50	9.56	3.94	2.22

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	-287.65	-95.64	-128.68	-196.04	-346.15	-331.13
Capital Expenditures CapEx Growth	-7.03	-10.01	-7.27	-2.17	-	-0.22
Free Cash Flow Free Cash Flow Growth	-294.68	-105.65	-135.95	-198.21	-346.15	-331.35
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	57.35%	-16.83%	83.00%	87.73%	25.32%	99.06%
Operating Margin	-323.92%	-1796.85%	-122.51%	-907.98%	-29024.26%	-1332.01%
Pretax Margin	-356.97%	-884.72%	-125.26%	-962.61%	-30919.62%	-1396.55%
Profit Margin	-361.42%	-880.10%	-140.22%	-1032.84%	-30895.21%	-1405.18%
FCF Margin	-560.39%	-1112.70%	-94.83%	-635.85%	-26323.19%	-1161.46%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PS Ratio	64.46	419.78	39.44	214.95	4502.47	118.82

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error